Evidence map›Paper›PMID 42016024›Full record

ReviewInternational journal of molecular and cellular medicine2025

Trace Amine-associated Receptor 1: Role in the Implementation of Neuroprotective Signaling Pathways.

Mikhail Voevoda, Dmitry Filimonov, Roman Knyazev, Roman Ishchenko, Alexander Eresko, Nadezhda Trubnikova, Margarita Belotserkovskaya, Irina Kisilenko, Inna Nosova, Maksim Solopov

Abstract readReview
In one paragraph

Review in International journal of molecular and cellular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mikhail VoevodaFederal State Budgetary Scientific Institution and quot, Federal Research Center for Fundamental and Translational Medicine and quot, Novosibirsk, Russia.
Dmitry FilimonovFederal State Budgetary Institution "V.K. Gusak Institute of emergency and reconstructive surgery" of the Ministry of health of the Russian.
Roman KnyazevFederal State Budgetary Scientific Institution and quot, Federal Research Center for Fundamental and Translational Medicine and quot, Novosibirsk, Russia.
Roman IshchenkoFederal State Budgetary Institution "V.K. Gusak Institute of emergency and reconstructive surgery" of the Ministry of health of the Russian.
Alexander EreskoFrank Laboratory of Neutron Physics, Joint Institute for Nuclear Research, Dubna, Russia.
Nadezhda TrubnikovaFederal State Budgetary Institution "V.K. Gusak Institute of emergency and reconstructive surgery" of the Ministry of health of the Russian.
Margarita BelotserkovskayaFederal State Budgetary Institution "V.K. Gusak Institute of emergency and reconstructive surgery" of the Ministry of health of the Russian.
Irina KisilenkoFederal State Budgetary Institution "V.K. Gusak Institute of emergency and reconstructive surgery" of the Ministry of health of the Russian.
Inna NosovaFederal State Budgetary Institution "V.K. Gusak Institute of emergency and reconstructive surgery" of the Ministry of health of the Russian.
Maksim SolopovFederal State Budgetary Institution "V.K. Gusak Institute of emergency and reconstructive surgery" of the Ministry of health of the Russian.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trace amine-associated receptor 1 (TAAR1) is a classical representative of G-protein coupled receptors (GPCRs). It is widely distributed in the mammalian brain, potentially plays an important role in modulating neurotransmitter functions and may regulate synaptic transmission and neuronal activity. Studies on TAAR1 signaling pathways were reviewed to identify the potential of TAAR1 as a novel target for neuroprotection and neurorepair. TAAR1 realizes effects through binding to the G-protein subunits Gas or Ga13. The target of Gas is PKA and the target of Ga13 is RhoA. Among the RhoA-mediated effects of TAAR1, effects on MAPK/ERK pathway kinases, AMPA and NMDA glutamate receptors and CREB factor have been investigated. RhoA-mediated effects include effects on the internalization of DAT and EAAT3, neuronal transporters of dopamine and glutamate. A G-protein independent pathway is mediated by β-arrestin and is probably related to the formation of the TAAR1-D2R heterodimer. The modulatory effect of TAAR1 on neurotransmitter systems allows us to consider TAAR1 agonists as potential therapeutic agents for the treatment of neurodegenerative diseases and psychiatric disorders, as well as neuroprotectors in ischemic brain damage.

Indexed as

Cyclic AMP-dependent protein kinasesNeuroprotectionNeurotransmitter agentsSignal transductionTrace amine-associated receptors

Identifiers

PMID42016024
PMCPMC13092835

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.